AR045625A1 - Sintesis de 4-amino-5-cloro-2-metoxi-n-(1-azabiciclo [3.3.1]non-4-il)benzamida - Google Patents

Sintesis de 4-amino-5-cloro-2-metoxi-n-(1-azabiciclo [3.3.1]non-4-il)benzamida

Info

Publication number
AR045625A1
AR045625A1 ARP040103240A ARP040103240A AR045625A1 AR 045625 A1 AR045625 A1 AR 045625A1 AR P040103240 A ARP040103240 A AR P040103240A AR P040103240 A ARP040103240 A AR P040103240A AR 045625 A1 AR045625 A1 AR 045625A1
Authority
AR
Argentina
Prior art keywords
formula
chloro
amino
acid
azabiciclo
Prior art date
Application number
ARP040103240A
Other languages
English (en)
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Publication of AR045625A1 publication Critical patent/AR045625A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La presente se relaciona con un proceso mejorado para la producción de clorhidrato de [(-+)-endo]-4-amino-5-cloro-2-metoxi-N-(1-azabiciclo[3.3.1]non-4-il)benzamida, y sus intermediarios. Este compuesto es útil en el tratamiento de trastornos gástricos. Reivindicación 1 Un proceso para la preparación de compuesto de fórmula (1), que comprende a) preparar cloruro ácido de fórmula (2), a partir de ácido de fórmula (3), haciendo reaccionar el ácido (3) con cloruro de oxalilo o cloruro de tionilo, en diclorometano, tolueno, dimetilformamida (DMF) o tetrahidrofurano (THF); b) hacer reaccionar el cloruro ácido (2) en tolueno, con amina de fórmula (4) y aislar de allí el producto de fórmula (5).
ARP040103240A 2003-09-09 2004-09-09 Sintesis de 4-amino-5-cloro-2-metoxi-n-(1-azabiciclo [3.3.1]non-4-il)benzamida AR045625A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0321091.1A GB0321091D0 (en) 2003-09-09 2003-09-09 Synthesis

Publications (1)

Publication Number Publication Date
AR045625A1 true AR045625A1 (es) 2005-11-02

Family

ID=29226752

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103240A AR045625A1 (es) 2003-09-09 2004-09-09 Sintesis de 4-amino-5-cloro-2-metoxi-n-(1-azabiciclo [3.3.1]non-4-il)benzamida

Country Status (17)

Country Link
US (2) US7189852B2 (es)
EP (1) EP1664048A2 (es)
JP (1) JP2007505089A (es)
KR (1) KR20060092211A (es)
CN (1) CN1849320A (es)
AR (1) AR045625A1 (es)
AU (1) AU2004270465A1 (es)
BR (1) BRPI0414200A (es)
CA (1) CA2537536A1 (es)
EA (1) EA200600563A1 (es)
GB (1) GB0321091D0 (es)
IL (1) IL173736A0 (es)
MX (1) MXPA06002743A (es)
NO (1) NO20061575L (es)
TW (1) TW200526661A (es)
WO (1) WO2005023808A2 (es)
ZA (1) ZA200601991B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080008933A1 (en) * 2005-12-23 2008-01-10 Boston-Power, Inc. Lithium-ion secondary battery
US7811707B2 (en) * 2004-12-28 2010-10-12 Boston-Power, Inc. Lithium-ion secondary battery
TWI426678B (zh) * 2006-06-28 2014-02-11 Boston Power Inc 具有多重充電率之電子裝置、電池組、充電於電子裝置中的鋰離子電荷儲存電源供應器之方法及可攜式電腦
US20090297937A1 (en) * 2008-04-24 2009-12-03 Lampe-Onnerud Christina M Lithium-ion secondary battery
WO2010030875A1 (en) * 2008-09-12 2010-03-18 Boston-Power, Inc. Method and apparatus for embedded battery cells and thermal management
WO2010135260A2 (en) * 2009-05-18 2010-11-25 Boston-Power, Inc. Energy efficient and fast charge modes of a rechargeable battery
US20110049977A1 (en) * 2009-09-01 2011-03-03 Boston-Power, Inc. Safety and performance optimized controls for large scale electric vehicle battery systems
EP2819212A1 (en) * 2009-09-01 2014-12-31 Boston-Power, Inc. Large scale battery systems and method of assembly
CN111032699B (zh) 2017-07-21 2022-08-02 罗门哈斯公司 聚(甲基丙烯酸甲酯)树脂组合物
US20220298107A1 (en) * 2019-08-29 2022-09-22 Janssen Biotech, Inc. Substituted urea dihydroorotate dehydrogenase inhibitors
CN112094239A (zh) * 2020-11-03 2020-12-18 燃点(南京)生物医药科技有限公司 一种乌拉地尔杂质化合物、制备方法及其应用
CN113773219B (zh) * 2021-09-30 2024-08-13 内蒙古康普药业有限公司 一种甲氧氯普胺双氯杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119724B2 (de) 1970-04-24 1976-04-29 Teikoku Hormone Manufacturing Co. Ltd., Tokio Verfahren zur herstellung einer halogensubstituierten benzoesaeure
JPS5010573B1 (es) * 1970-04-24 1975-04-22
AU563225B2 (en) * 1982-04-14 1987-07-02 Alizyme Therapeutics Limited I-aza bicyclic compounds
US4612319A (en) * 1982-04-14 1986-09-16 Beecham Group P.L.C. Bridged quinolizidinylbenzamides, compositions containing them and methods for their use
GB8523211D0 (en) * 1985-09-19 1985-10-23 Beecham Group Plc Compounds
GB8607163D0 (en) 1986-03-22 1986-04-30 Beecham Group Plc Chemical compound
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
US5140023A (en) 1990-04-27 1992-08-18 G. D. Searle & Co. Azatetracycle compounds
KR970701705A (ko) 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
GB0329319D0 (en) * 2003-12-18 2004-01-21 Alizyme Therapeutics Ltd Synthesis

Also Published As

Publication number Publication date
NO20061575L (no) 2006-06-09
US20050049416A1 (en) 2005-03-03
ZA200601991B (en) 2009-08-26
MXPA06002743A (es) 2006-06-05
WO2005023808A3 (en) 2005-07-07
TW200526661A (en) 2005-08-16
EA200600563A1 (ru) 2006-12-29
US7189852B2 (en) 2007-03-13
IL173736A0 (en) 2006-07-05
KR20060092211A (ko) 2006-08-22
BRPI0414200A (pt) 2006-10-31
CA2537536A1 (en) 2005-03-17
GB0321091D0 (en) 2003-10-08
US20070135641A1 (en) 2007-06-14
WO2005023808A2 (en) 2005-03-17
EP1664048A2 (en) 2006-06-07
AU2004270465A1 (en) 2005-03-17
CN1849320A (zh) 2006-10-18
JP2007505089A (ja) 2007-03-08

Similar Documents

Publication Publication Date Title
AR045625A1 (es) Sintesis de 4-amino-5-cloro-2-metoxi-n-(1-azabiciclo [3.3.1]non-4-il)benzamida
US6025516A (en) Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
IS7915A (is) Ferli til að framleiða dúlóxetín og milliefni tilnotkunar í ferlinu
DE502004003355D1 (de) Verfahren zur herstellung von ethylenaminen
CN102295594B (zh) 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
CY1111277T1 (el) Μεθοδος παραγωγης κιλοσταζολης
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
ZA201003751B (en) Process for the synthesis of propargylated aminoindan derivatives
HK1075052A1 (en) Intermediates for lhrh antagonist synthesis, proc ess for their production, and process for lhrh antagonist production
CN104356110B (zh) 一种硫诱导3,6‑芳香杂环不对称取代‑1,2,4,5‑四嗪化合物及其合成方法
CA2488034C (en) Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
IL146758A0 (en) Process for production of amic acid ester
CA2286914C (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
HUP0302903A2 (hu) Eljárás királis vegyületek előállítására
CN106631827B (zh) 一种(1-环丙基-1-甲基)乙基胺及其盐酸盐的合成方法
KR950000686A (ko) 에르도스테인의 제조과정
WO2006072375A3 (de) Verfahren zur herstellung von substituierten 2-alkoxycarbonyl-3-aminothiophenen
EP1700852A4 (en) PROCESS FOR THE PRODUCTION OF 3- (4-TETRAHYDROPYRANYL) -3-OXOPROPIONATE ALKYL AND 4-ACYLTETRAHYDROPYRAN COMPOUND
JP2671401B2 (ja) α‐アミノチオアセトアミド誘導体およびその製造法
US20040006225A1 (en) Preparation of enantiomerically enriched amine-functionalized compounds
TH79589A (th) การสังเคราะห์แบบไม่สมมาตรของไดไฮโดรเบนโซฟิวรานที่ถูกแทนที่
TW200505870A (en) Process for synthesizing heterocyclic compounds
TH79589B (th) การสังเคราะห์แบบไม่สมมาตรของไดไฮโดรเบนโซฟิวรานที่ถูกแทนที่
HUP0303440A2 (hu) Eljárás 1-klór-4-arilbután-származékok előállítására
ES2115239T3 (es) Procedimiento de produccion de alfa-hidroxiiminofenilacetonitrilos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal